Spero Therapeutics Inc.

10/28/2021 | Press release | Distributed by Public on 10/28/2021 06:13

Spero Therapeutics Submits New Drug Application to U.S. FDA for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including Pyelonephritis